We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Vaccine Development Evaluation Centre (VDEC) at Porton Down in Wiltshire facilitates the development and evaluation of new vaccines and therapeutics.
When military end-use export controls apply and to which destinations.
This guidance explains what rules of origin (RoOs) are and the changes under the Developing Countries Trading Scheme (DCTS).
How to claim R&D expenditure credit (RDEC) for Corporation Tax relief on your company's R&D, if you’re a large company or small and medium-sized enterprise.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Guidance on choosing evaluation study types and methods.
How end-use controls apply to weapons of mass destruction (WMD) related goods, software, technology and technical assistance.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How to use a contextual inquiry when developing your digital health product.
Sets out special provisions for Crown development for dealing with security-sensitive information in planning applications.
How to use an N-of-1 study to evaluate your digital health product.
How to use a randomised controlled trial to evaluate your digital health product.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
The process for applicants applying for a Paediatric Investigation Plan (PIP) modification or waiver.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Guidance for manufacturers, importers and distributors.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a cost effectiveness analysis to evaluate your digital health product.
The sale of land is determined by the potential number of homes that a housing developer or registered provider can build on a given site.
Descriptions of team capabilities on the Digital Outcomes and Specialists framework.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.